(Q46303987)

English

Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

0 references

ulcerative colitis

1 reference

based on heuristic

inferred from title

author name string

Reikei Matsuda

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Tomoko Koide

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Chikako Tokoro

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Tsuyoshi Yamamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Ten'i Godai

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Taiki Morohashi

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Yuji Fujita

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Daisuke Takahashi

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Ichiro Kawana

9

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Shinichiro Suzuki

10

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Satoshi Umemura

11

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

publication date

1 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

15

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

328-334

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

Alterations of the mucosal immune system in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Therapeutic leukocytapheresis for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Cytokines in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Interleukin-1 receptor antagonist as therapy for inflammatory disorders

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

IL-1beta genotype-related effect of prednisolone on IL-1beta production in human peripheral blood mononuclear cells under acute inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20759

21 January 2018

Identifiers

10.1002/IBD.20759

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18942752

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46303987&oldid=2104242799"